CIK 0000010795
- Large accelerated filer
BECTON DICKINSON & CO
Sign in to watch- Ticker
- BDX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 220760120
- Phone
- +1 201-847-6800
- Business address
- ONE BECTON DR, FRANKLIN LAKES, NJ, 07417-1880
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $688,650
- in 4 filings, $689K under 10b5-1 plans
Net −$688,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-05 | Byington Carrie L Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +128 | $233.59 | $30K | 1,424 |
| 2024-09-07 | DelOrefice Christopher EVP & Chief Financial Officer | Shares withheld for taxes | −466 | 12,792 | ||
| 2024-09-01 | Byrd Richard EVP & President Interventional | Shares withheld for taxes | −216 | 6,060 | ||
| 2024-09-01 | DelOrefice Christopher EVP & Chief Financial Officer | Shares withheld for taxes | −254 | 13,258 | ||
| 2024-08-20 | Feld Michael EVP & President, Life Sciences | Grant or award | +6,637 | 6,637 | ||
| 2024-08-14 | Goette Roland EVP and President EMEA | Exercise or conversion 10b5-1 | +5,295 | $132.54 | $702K | 16,603 |
| 2024-08-14 | Goette Roland EVP and President EMEA | Returned to the company 10b5-1 | −4,018 | $234.08 | $941K | 12,585 |
| 2024-08-14 | Goette Roland EVP and President EMEA | Exercise or conversion · Stock Appreciated Rights 10b5-1 | −5,295 | 0 | ||
| 2024-07-31 | Jones Christopher Ian Montague Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +124 | $241.05 | $30K | 10,224 |
| 2024-07-31 | Byington Carrie L Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +124 | $241.05 | $30K | 1,291 |
| 2024-07-01 | Spoerel Thomas J SVPController & Chief Acct Off | Shares withheld for taxes | −48 | 1,928 | ||
| 2024-06-10 | Spoerel Thomas J SVP,Controller&Chief Acct Off | Sale 10b5-1 | −300 | $239.31 | $72K | 1,976 |
| 2024-05-15 | Goette Roland EVP and President EMEA | Sale 10b5-1 | −800 | $235.29 | $188K | 13,808 |
| 2024-05-15 | Goette Roland EVP and President EMEA | Sale 10b5-1 | −1,400 | $236.99 | $332K | 12,408 |
| 2024-05-15 | Goette Roland EVP and President EMEA | Sale 10b5-1 | −1,100 | $237.46 | $261K | 11,308 |
| 2024-05-13 | Goette Roland EVP and President EMEA | Sale 10b5-1 | −1,700 | $236.28 | $402K | 16,208 |
| 2024-05-13 | Goette Roland EVP and President EMEA | Sale 10b5-1 | −1,572 | $237.14 | $373K | 14,636 |
| 2024-05-13 | Goette Roland EVP and President EMEA | Sale 10b5-1 | −28 | $237.90 | $7K | 14,608 |
| 2024-05-03 | Byington Carrie L Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +129 | $233.44 | $30K | 1,162 |
| 2024-05-03 | Jones Christopher Ian Montague Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +129 | $233.44 | $30K | 9,954 |
Page 11 of 28 · 548 trades